LMR Partners’s Opko Health OPK Stock Holding History

LMR Partners’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-140,994	Closed	-$207	–	391
2019 Q4	$207	Buy	+140,994	New	+$236K	﹤0.01%	373

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LMR Partners's OPK Position: Q1 2020 in Review

LMR Partners sold out of Opko Health (OPK) in Q1 2020, closing a stake of 140,994 shares — an estimated $207 sold.

LMR Partners first reported a position in OPK in Q4 2019 and held it in 1 quarter. The position peaked at $207 in Q4 2019. 181 funds tracked by Wall St. Rank hold OPK as of Q1 2020.

LMR Partners reported no remaining Opko Health position as of Q1 2020 after selling out during the quarter.
LMR Partners sold 140,994 Opko Health shares in Q1 2020, an estimated $207.
LMR Partners first reported a position in Opko Health in Q4 2019 and held it in 1 quarter.
LMR Partners's Opko Health position peaked at $207 in Q4 2019.
181 funds tracked by Wall St. Rank held Opko Health as of Q1 2020.

Based on LMR Partners's 13F filing for Q1 2020, filed 15 May 2020.